Member Type: Diagnostic Companies
Asuragen, Inc. is a molecular biology service provider and integrated diagnostic company focused on oncology. Asuragen’s Pharmaceutical Services Division provides a comprehensive range of Good Laboratory Practice and GCP services for mRNA, DNA, and miRNA projects.Service offerings range from biomarker discovery, pre-clinical, and clinical testing services to assay development and companion diagnostic partnerships. The Asuragen Diagnostics Division combines molecular biology assay design and development expertise and state of the art cGMP manufacturing capability. Asuragen’s CLIA laboratory provides mutation testing (KRAS and BRAF); novel miRNA molecular tests and serves as a platform for the commercialization of companion diagnostics.